Indeed, some authors found NOTCH1 mutated in 11% of CLL patients and found that mutations in this gene are in 90% of the cases mutually exclusive with TP53 disruptions, and confer a similarly dismal prognosis with a reduction in the overall survival (OS) [41]. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.